Table 1.
Gene | Name | Fold increase in SCI1 | Fold increase in TBI2 | Function in CNS injury3 | HuR Binding Sites4 |
---|---|---|---|---|---|
IL-1β | Interleukin 1β | 160 | 34 | I, C | 4 |
LIF | Leukemia inhibitory factor | 32 | 16 | I, C | 20 |
IL-6 | Interleukin 6 | 168 | 48 | I | 4 |
TNF-α | Tumor necrosis factor alpha | 23 | 610 | I, C, E | 12 |
CXCL1 | C-X-C motif chemokine ligand 1 | n.a. | 161 | C | 9 |
CCL2 | C-C motif ligand 2 | 230 | 144 | C | 4 |
MMP12 | Matrix metalloproteinase-12 | 189 | 154 | I, E | 9 |
Based on data published elsewhere ranking the relevance of gene responses in spinal cord injury.22,51
Based on data published elsewhere investigating mRNA expression in response to traumatic brain injury.23
I, inflammation; C, chemotaxis; E, edema.
Binding sites located in 3′ untranslated region of mRNA based on consensus sequences identified previously.24,25
CNS, central nervous system; HuR, human antigen R; mRNA, messenger RNA; SCI, spinal cord injury; TBI, traumatic brain injury.